Nieuws
HUB and Pfizer will collaborate on human gut organoids for IBD
HUB today announced a collaboration with Pfizer Inc. that aims to develop a Human Gut Organoid Technology Platform to aid in research related to potential treatments for Inflammatory Bowel Disease (IBD).Forming model embryos from stem cells in the lab
Scientists from the MERLN Institute and the Hubrecht Institute (KNAW) have successfully created in the laboratory embryo-like structures from mouse stem cells. These model embryos resemble natural ones to the extent that, for the first time, they implant into the uterus and initiate pregnancy. This radically new method opens the door to understanding the first and hidden processes of life, problems of infertility, or the embryonic origin of diseases. This scientific breakthrough has been published in Nature.
EMA 2017 annual report published
EMA's 2017 annual report highlights the major achievements and includes key figures.
Seventeen million euros for Netherlands X-omics Initiative
The Netherlands X-omics Initiative, led by Radboud university medical center, has received 17 million euros from the Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap for Large-Scale Research Facilities. The X-omics Initiative is one of ten projects awarded by Minister of Education, Culture and Science Ingrid van Engelshoven. A total of 138 million euros has been allocated to facilitate a large-scale research infrastructure in the Netherlands.
Minister Ingrid van Engelshoven visited InSciTe to learn about the unique matrix concept to accelerate the road from patent to patient
On monday 16 April, Minister of Education, Culture and Science Ingrid van Engelshoven visited the biomedical facility of the Institute for Science and Technology (InSciTe) in Geleen as part of a work visit to the Brightlands Chemelot Campus.
Update from The Hague: New government embraces innovation as the way forward
The Dutch government’s ambitions, set out in its coalition agreement 'Confidence in the Future’ published in October 2017, are rapidly being put into action. In this ‘Update from The Hague’, the most relevant policy developments regarding funding and innovation for Life Sciences & Health (LSH) entrepreneurs and companies are addressed.
Health~Holland Update April 2018
The new Health~Holland Update April 2018 edition is out now. Read our magazine that brings you the latest developments in the Top Sector Life Sciences & Health and get insight in the blossoming initiatives and activities.
Succesful IMDI 2.0 kick-off
On Wednesday the 18th of April the IMDI 2.0 kick-off took place in Utrecht. During this afternoon Hans Rietman, chairman of the IMDI 2.0 steering group, presented the sequel of the IMDI subsidy programme. Henk Smid, director of ZonMw, also thanked Cor Spreeuwenberg as chairman of the IMDI initiative group for his help by setting up IMDI 2.0.
Faster the right medicine with cultured mini-brains
Hoe vind je direct het juiste medicijn voor kinderen met ernstige epilepsie zonder telkens andere medicijnen op de patiëntjes zelf te hoeven testen? Nieuwsuur bericht over onderzoek om die vraag te beantwoorden.
From matchmaking to fundraising: RVO.nl is there for every healthcare innovator
De Rijksdienst voor Ondernemend Nederland (RVO.nl) biedt een keur aan regelingen en instrumenten voor zorgvernieuwers. Maar ze hebben nog veel meer te bieden. Wat dat is? Inge Valstar (Zorg voor innoveren) vroeg het Niels van Leeuwen en Jerry Kanhai van RVO.nl.